The association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma gene with serum osteoprotegerin levels in healthy Korean women.
- Author:
Eun Jung RHEE
1
;
Ki Won OH
;
Eun Joo YUN
;
Chan Hee JUNG
;
Cheol Young PARK
;
Won Young LEE
;
Eun Sook OH
;
Ki Hyun BAEK
;
Moo Il KANG
;
Sung Woo PARK
;
Sun Woo KIM
Author Information
1. Department of Endocrinology and Metabolism, Sungkyunkwan University School of Medicine, Seoul 135-710, Korea. okwendo@yahoo.co.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
alkaline phosphatase;
bone and bones;
PPAR-gamma;
polymorphism, genetic;
osteoprotegerin
- MeSH:
Alanine/genetics;
*Amino Acid Substitution;
Asian Continental Ancestry Group;
Bone Density/physiology;
Bone and Bones/*metabolism;
Enzyme-Linked Immunosorbent Assay;
Female;
Gene Frequency;
Humans;
Korea;
Middle Aged;
*Mutation;
Osteoprotegerin/*blood/metabolism;
PPAR gamma/*genetics/metabolism;
Polymorphism, Genetic;
Proline/genetics
- From:Experimental & Molecular Medicine
2007;39(6):696-704
- CountryRepublic of Korea
- Language:English
-
Abstract:
Recent evidences suggest that the activation of peroxisome proliferator-activated receptor (PPAR)-gamma, which is an important transcriptional factor in adipocyte differentiation, also plays an important role in the bone microenvironment. The objective of the study was to clarify whether Pro12Ala polymorphism was related to the serum OPG levels and bone mineral metabolism in healthy Korean women. In 239 Korean women (mean age 51 years), who participated in medical check-up program in a health promotion center, anthropometric measurements, lumbar spine and femoral neck bone mineral density (BMD), bone turnover markers, such as serum total alkaline phosphatase (ALP) levels, urine deoxypyridinoline levels, and 24-h urine calcium excretion were measured. Serum levels of OPG were measured with ELISA method. DNAs were extracted from the samples and the genotyping of the Pro12Ala polymorphism (rs1801282) in the PPAR-gamma gene was performed via an allelic discrimination assay using a TaqMan probe. In addition, we examined the haplotype analysis between two polymorphisms of PPAR-gamma gene, Pro12Ala in exon B and C161T in exon 6 (rs3856806). Allelic frequencies were 0.950 for Pro allele and 0.050 for Ala allele, which was in compliance with Hardy- Weinberg equilibrium, and there was no Ala12Ala genotype among the genotyped subjects. Mean serum OPG level was significantly lower (P=0.035), and serum total ALP was significantly higher (P=0.014) in the Pro12Ala genotype group compared with the Pro12Pro genotype group, which were consistently significant even after adjustment for weight, height, and serum follicle stimulating hormone (FSH). In multiple regression analysis with serum OPG as the dependent variable and age, weight, ALP, femoral neck BMD and Pro12Ala genotype included in the model, only Pro12Ala genotype was significant determinant of serum OPG level (beta=-0.136, P=0.035). The haplotype analysis with C161T polymorphism revealed that subjects with Ala and T alleles showed significantly lower serum OPG levels compared with those with Pro12Pro/CC genotype, which were consistently significant even after adjustment for age, weight, height and FSH (P=0.010). This result suggests statistically significant association of Pro12Ala polymorphisms with serum OPG levels in Korean females.
